U.S. Pharmaceuticals & Biotech Most Popular Stocks

Voyager Therapeutics

Market Cap: US$235.7m

A biotechnology company, focuses on the human genetics for the cure of neurological diseases.

Zhengye Biotechnology Holding

Market Cap: US$235.5m

Engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China.

Fennec Pharmaceuticals

Market Cap: US$233.8m

Operates as a commercial stage biopharmaceutical company in the United States.

Atea Pharmaceuticals

Market Cap: US$230.1m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections.

NeOnc Technologies Holdings

Market Cap: US$229.9m

A clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies.

Heron Therapeutics

Market Cap: US$229.1m

A commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.

OmniAb

Market Cap: US$227.4m

A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.

Cabaletta Bio

Market Cap: US$225.9m

A clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases.

Codexis

Market Cap: US$223.9m

Provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China.

Ironwood Pharmaceuticals

Market Cap: US$222.5m

A biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally.

ProQR Therapeutics

Market Cap: US$221.2m

A biotechnology company, focuses on the discovery and development of novel therapeutic medicines.

Tiziana Life Sciences

Market Cap: US$219.6m

A biotechnology company, engages in the development of transformative therapies for neurodegenerative and lung diseases in the United States.

MDxHealth

Market Cap: US$216.8m

A commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally.

Tonix Pharmaceuticals Holding

Market Cap: US$216.5m

A biopharmaceutical company, focuses on developing and commercializing therapeutics to treat and prevent human disease.

VitaSpring Biomedical

Market Cap: US$207.0m

Focuses on the development of drugs of cell medicine.

Aclaris Therapeutics

Market Cap: US$202.6m

A clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States.

Caribou Biosciences

Market Cap: US$198.4m

A clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and autoimmune diseases in the United States and internationally.

Ventyx Biosciences

Market Cap: US$196.1m

A clinical-stage biopharmaceutical company, develops oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases.

MediWound

Market Cap: US$196.0m

A biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally.

BioAge Labs

Market Cap: US$190.4m

A biopharmaceutical company that develops therapeutic product candidates for metabolic diseases.

Milestone Pharmaceuticals

Market Cap: US$189.9m

A biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada.

Journey Medical

Market Cap: US$189.4m

Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Coherus Oncology

Market Cap: US$183.6m

A biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.

Entrada Therapeutics

Market Cap: US$183.1m

A clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases.

China SXT Pharmaceuticals

Market Cap: US$182.2m

A pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China.

Elicio Therapeutics

Market Cap: US$180.4m

A clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer.

Black Diamond Therapeutics

Market Cap: US$177.1m

A clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors.

MaxCyte

Market Cap: US$177.0m

A life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally.

C4 Therapeutics

Market Cap: US$172.2m

A clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins.

SELLAS Life Sciences Group

Market Cap: US$171.6m

A late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States.

Sangamo Therapeutics

Market Cap: US$170.4m

A clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States.

Seres Therapeutics

Market Cap: US$169.8m

A clinical-stage company, focuses on developing biotherapeutics for serious diseases.

Enanta Pharmaceuticals

Market Cap: US$167.0m

A biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases.

Protalix BioTherapeutics

Market Cap: US$164.2m

A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.

Genelux

Market Cap: US$163.2m

A clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types.

Actuate Therapeutics

Market Cap: US$160.9m

A clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States.